| William Austin Davis, | |
|
500 Walter St Ne Ste 213, Albuquerque, NM 87102-2543 | |
| (505) 727-7177 | |
| Not Available |
| Full Name | William Austin Davis |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 500 Walter St Ne Ste 213, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285024737 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MT214505 (Pennsylvania) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | MD2022-1084 (New Mexico) | Primary |
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
BTG plc, the global healthcare company, highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and Interventions in San Diego, California.
Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors.
COVID-19 has changed the world in unimaginable ways. Some have even been positive, with new vaccines developed in record time. Even the extraordinary lockdowns, which have had severe effects on movement and commerce, have had beneficial effects on the environment and therefore, ironically, on health.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the close of its $16 million Series D round of financing. Current investors Caxton Advantage Life Sciences Fund LP and Sanderling Venture Partners co-led the round. In addition, the Series D structure grants certain current investors the option to invest an additional $4 million in this financing round in the future.
As mobile devices become increasingly ubiquitous and play ever more significant roles in our lives, ensuring the trustworthiness and security of the information being exchanged has never been more important.
› Verified 9 days ago
| Entity Name | Lovelace Unm Rehabilitation Hospital, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700325677 PECOS PAC ID: 5799061917 Enrollment ID: O20170424000991 |
News Archive
BTG plc, the global healthcare company, highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and Interventions in San Diego, California.
Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors.
COVID-19 has changed the world in unimaginable ways. Some have even been positive, with new vaccines developed in record time. Even the extraordinary lockdowns, which have had severe effects on movement and commerce, have had beneficial effects on the environment and therefore, ironically, on health.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the close of its $16 million Series D round of financing. Current investors Caxton Advantage Life Sciences Fund LP and Sanderling Venture Partners co-led the round. In addition, the Series D structure grants certain current investors the option to invest an additional $4 million in this financing round in the future.
As mobile devices become increasingly ubiquitous and play ever more significant roles in our lives, ensuring the trustworthiness and security of the information being exchanged has never been more important.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Austin Davis, 4101 Indian School Rd Ne Ste 110, Albuquerque, NM 87110-3991 Ph: (505) 727-7177 | William Austin Davis, 500 Walter St Ne Ste 213, Albuquerque, NM 87102-2543 Ph: (505) 727-7177 |
News Archive
BTG plc, the global healthcare company, highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and Interventions in San Diego, California.
Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors.
COVID-19 has changed the world in unimaginable ways. Some have even been positive, with new vaccines developed in record time. Even the extraordinary lockdowns, which have had severe effects on movement and commerce, have had beneficial effects on the environment and therefore, ironically, on health.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the close of its $16 million Series D round of financing. Current investors Caxton Advantage Life Sciences Fund LP and Sanderling Venture Partners co-led the round. In addition, the Series D structure grants certain current investors the option to invest an additional $4 million in this financing round in the future.
As mobile devices become increasingly ubiquitous and play ever more significant roles in our lives, ensuring the trustworthiness and security of the information being exchanged has never been more important.
› Verified 9 days ago
Mark A Gould, PA Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1524 Eubank Blvd Ne Ste 6, Albuquerque, NM 87112 Phone: 505-503-8806 Fax: 888-503-8511 | |
Dr. Julie A Muche, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 541-342-2134 Fax: 541-242-4227 | |
Clifford R Stoller, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6100 Seagull St Ne, Suite 106, Albuquerque, NM 87109 Phone: 505-883-4395 Fax: 505-883-4397 | |
Joy Iris Schoenherr, P.T., D.P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 818 Menaul Blvd Nw, Albuquerque, NM 87107 Phone: 505-242-4079 Fax: 505-242-2094 | |
Ms. Debra Green, MSN, C-FNP Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1524 Eubank Blvd Ne Ste 6, Albuquerque, NM 87112 Phone: 505-503-8600 Fax: 888-503-8511 | |
Dr. Joshu Alan Raiten, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 500 Walter St Ne, Albuquerque, NM 87102 Phone: 505-727-7177 Fax: 505-727-3778 | |
Denise Evette Taylor, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1127 University Blvd Ne, Carrie Tingley Hospital, Albuquerque, NM 87102 Phone: 505-272-5271 Fax: 505-272-6500 |